Login / Signup

TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer.

Christos VaklavasBrian S RobertsKatherine E VarleyNancy U LinMinetta C LiuHope S RugoShannon PuhallaRita NandaAnna Maria StornioloLisa A CareyMansoor N SalehYufeng LiJennifer F DelossantosWilliam E GrizzleAlbert F LoBuglioRichard M MyersAndres Forero-Torresnull null
Published in: Breast cancer research : BCR (2020)
This trial is registered with ClinicalTrials.gov (Identifier: NCT00161291), first posted on September 12, 2005, and is completed.
Keyphrases